Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Sanofi's Chief Digital Officer Emmanuel Frenehard had a thought that he just couldn't shake: how can Sanofi extend the ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

Sanofi, a leading global healthcare company, has received the “Corporate Social Impact Award 2024 – Gold level” for the fifth ...

Memphis-Shelby County Schools is suing multiple drug companies. Attorneys call it a mass action lawsuit, with nearly 100 ...

November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

One of the primary challenges in the regulatory affairs of the pharmaceutical industry is keeping pace with the ever-evolving regulatory landscape.

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

CHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction ...